StockWatch
·

BLISS GVS PHARMA LTD. Q2 FY27 Results

BLISSGVSQ2 FY27 Results
Filing
Result:Very Good· Market: Crashed#Broad based#Margin expansion
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue313.379.7%28.2%
Total Income321.679.0%21.6%
Expenditure246.5712.2%10.1%
PBT75.100.5%84.8%
Net Profit53.343.8%86.6%
OPM25.72%1.03pp12.73pp
NPM16.58%0.82pp5.77pp
EPS4.924.0%90.7%
View full financials

Revenue up 28.2% YoY with OPM nearly doubling (12.99%→25.72%) and PAT up 86.6%, and the growth is core-driven since other income actually fell YoY — a genuine standout for a pharma/formulations business.

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue313.379.7%28.2%
Total Income321.679.0%21.6%
Expenditure246.5712.2%10.1%
PBT75.100.5%84.8%
Net Profit53.343.8%86.6%
OPM25.72%1.03pp12.73pp
NPM16.58%0.82pp5.77pp
EPS4.924.0%90.7%
View full financials

Detailed report is being prepared.

Informational and educational content only. Not investment advice.